Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 1995; 74(01): 172-179DOI: 10.1055/s-0038-1642672 Symposium Molecular Basis of Fibrinolysis Schattauer GmbH Stuttgart The Enigma PAI-2. Gene Expression, Evolutionary and Functional Aspects F Bachmann Department of Medicine, Höpital Nestlé, University of Lausanne Medical Center, Lausanne, Switzerland › Institutsangaben Artikel empfehlen Abstract als PDF herunterladen Artikel einzeln kaufen PDF (747 kb) Referenzen References 1 Kawano T, Morimoto K, Uemura Y. Urokinase inhibitor in human placenta. Nature 1968; 217: 253-254 2 Kawano T, Morimoto K, Uemura Y. Partial purification and properties of urokinase inhibitor from human placenta. J Biochem 1970 67: 333-342 3 Golder JP, Stephens RW. Minactivin: A human monocyte product which specifically inactivates urokinase-type plasminogen activators. Eur J Biochem 1983; 136: 517-522 4 Vassalli JD, Dayer JM, Wohlwend A, Belin D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 1984; 159: 1653-1668 5 Kruithof EK O, Vassalli JD, Schleuning WD, Mattaliano RJ, Bachmann F. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem 1986; 261: 11207-11213 6 Schleuning WD, Medcalf RL, Hessian C, Rothenbühler R, Shaw MA, Kruithof EK O. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol 1987; 7: 4564-4567 7 Webb AC, Collins KL, Snyder SE, Alexander SJ, Rosenwasser LJ, Eddy RL, Shows TB, Auron PE. Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor. J Exp Med 1987; 166: 77-94 8 Wun TC, Reich E. An inhibitor of plasminogen activation from human placenta. Purification and characterization. J Biol Chem 1987; 262: 3646-3653 9 Antalis TM, Clark MA, Barnes T, Lehrbach PR, Devine PL, Schevzov G, Goss NH, Stephens RW, Tolstoshev P. Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci USA 1988; 85: 985-989 10 Kruithof EK O, Cousin E. Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the gene Biochem Biophys Res Commun 1988; 156: 383-388 11 Ye RD, Ahem SM, Le Beau MM, Lebo RV, Sadler JE. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem 1989; 264: 5495-5502 12 Sarnia JA, Alexander SJ, Horton KW, Auron PE, Byers MG, Shows TB, Webb AC. Chromosomal organization and localization of the human urokinase inhibitor gene: perfect structural conservation with ovalbumin. Genomics 1990; 6: 159-167 13 Silverman GA, Jockel JI, Domer PH, Mohr RM, Taillon-MOler P, Korsmeyer SJ. Yeast artificial chromosome cloning of a two-megabase-size contig within chromosomal band 18q21 establishes physical linkage between BCL2 and plasminogen activator inhibitor type-2. Genomics 1991; 9: 219-228 14 Ye RD, Wun T, Sadler JE. Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U- 937 cells. J Biol Chem 1988; 263: 4869-4875 15 von Heijne G, Liljestrom P, Mikus P, Andersson H, Ny T. The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity. J Biol Chem 1991; 266: 15240-15243 16 Genton C, Kruithof EK O, Schleuning WD. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol 1987; 104: 705-712 17 Wohlwend A, Belin D, Vassalli J. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J Exp Med 1987; 165: 320-339 18 Ye RD, Wun T, Sadler JE. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J Biol Chem 1987; 262: 3718-3725 19 Belin D, Wohlwend A, Schleuning WD, Kruithof EK O, Vassalli JD. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. EMBO J 1989; 8: 3287-3294 20 Jensen PH, Schuler E, Woodrow G, Richardson M, Goss N, Hojrap P, Petersen TE, Rasmussen LK. A unique inteihelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83 Gln84 Gln86essential for transglutaminase-mediated cross-linking. J Biol Chem 1994; 269: 15394-15398 21 Radtke KP, Wenz KH, Heimburger N. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract Biol Chem Hoppe Seyler 1990; 371: 1119-1127 22 Ny T, Hansson L, Lawrence D, Leonardsson G, Astedt B. Plasminogen activator inhibitor type 2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted. Fibrinolysis 1989; 3: 189-196 23 Mikus P, Urano T, Liljestrom P, Ny T. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms EurJ Biochem 1993; 218: 1071-1082 24 van den Berg EA, le Clercq E, Kooistra T, Frants RR, Bakker E. The human gene for plasminogen activator inhibitor 2 (PAI2) exhibits an EcoRl RFLP. Nucleic Acids Res 1990; 18: 2837-2837 25 Young J, Antalis TM, Chenevix-Trench G. Bell RFLP of the plasminogen activator inhibitor type 2 gene (PLANH) on chromosome 18q21-q23. Nucleic Acids Res 1990; 18: 7196-7196 26 Kiso U, Kaudewitz H, Henschen A, Astedt B, Kruithof EK O, Bachmann F. Deteimination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinases. FEBS Lett 1988; 230: 51-56 27 Lomas DA, Evans DL, Finch JT, Carrell RW. The mechnism of Z oq-antitrypsin accumulation in the liver. Nature 1992; 357: 605-607 28 Miura Y, Kawabata SI, Iwanaga S. A limulus intracellular coagulation inhibitor with characteristics of the serpin superfamily. Purification, characterization, and cDNA cloning. J Biol Chem 1994; 269: 542-547 29 Stein PE, Leslie AG, Finch JT, Carrell RW. Crystal structure of uncleaved ovalbumin at 1.95 A resolution. J Mol Biol 1991; 221: 941-946 30 Pytel BA, Peppel K, Baglioni C. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor. J Cell Physiol 1990; 144: 416-422 31 Hunt LT, Dayhoff MO. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alphaj-proteinase inhibitor. Biochem Biophys Res Commun 1980; 95: 864-871 32 McReynolds L, O’Malley BW, Nisbet AD, Fothergill JE, Givol D, Fields S, Robertson M, Brownlee GG. Sequence of chicken ovalbumin mRNA. Nature 1978; 273: 723-728 33 Heilig R, Muraskowsky R, Kloepfer C, Mandel JL. The ovalbumin gene family: complete sequences and structure of the Y gene. Nucleic Acids Res 1982; 10: 4363-4382 34 Coughlin P, Sun J, Cerruti L, Salem HH, Bird P. Cloning and molecular characterization of a human intracellular serine proteinase inhibitor. Proc Natl Acad Sci USA 1993; 90: 9417-9421 35 Suminami Y, Kishi F, Sekiguchi K, Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. J Mol Biol 1991; 221: 941-946 36 Remold-O’Donnell E, Chin J, Alberts M. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc Natl Acad Sci USA 1992; 89: 5635-5639 37 Dubin A, Travis J, Enghild JJ, Potempa J. Equine leucocyte elastase inhibitor. Primary structure and identification as a thymosin-binding protein. J Biol Chem 1992; 267: 6576-6581 38 Remold-O’Donnell E. The ovalbumin family of serpin proteins. FEBS Lett 1993; 315: 105-108 39 Medcalf RL, Van den Berg E, Schleuning WD. Glucocorticoid-modulated gene expression of tissue- and urinary- type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol 1988; 106: 971-978 40 Medcalf RL, Kruithof EK O, Schleuning WD. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med 1988; 168: 751-759 41 Antalis TM, Godbolt D, Donnan KD, Stringer BW. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2. Gene 1993; 134: 201-208 42 Schuster WA, Medcalf RL, Kruithof EK O. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitortype 2 in human myeloid leukemic celllines. Endocrinology 1993; 133: 1724-1730 43 Schuster WA, Medcalf RL, Kruithof EK O. Localization and characterization of a retinoic acid response-like element in the plasminogen activator inhibitor-2 gene promoter. Fibrinolysis 1994; 8: 113-119 44 Nebert DW, Jones JE. Regulation of the mammalian cytochrome P1450 (CYP1A1) gene. Int J Biochem 1989; 21: 243-252 45 Sutter TR, Guzman K, Dold KM, Greenlee WF. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-lb. Science 1991; 254: 415-418 46 Gaido KW, Maness SC. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Phaimacol 1994; 127: 199-208 47 Cousin E, Medcalf RL, Bergonzelli GE, Kruithof EK O. Regulatory elements involved in constitutive and phorbol ester inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 1991; 19: 3881-3886 48 Angel P, Imagawa M, Chiu R, Stein B, Imbra R, Rahmsdorf Hi, Jonat C, Herrlich P, Karin M. Phorbol ester-inducible genes contain a common c is element recognized by a TPA-modulator trans-acting factor. Cell 1987; 49: 729-739 49 Medcalf RL. Cell-and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system. J Biol Chem 1992; 267: 12220-12226 50 Kumar S, Baglioni C. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 1991; 266: 20960-20964 51 Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and release during apoptosis. Proc Natl Acad Sci USA 1991; 88: 8485-8489 52 Jensen PH, Cressey LI, Gjertsen BT, Madsen P, Mellgren G, Hokland P, Gliemann J, Døskeland SO, Lanotte M, Vinteimyr OK. Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer 1994; 70: 834-840 53 Danesch U, Gloss B, Schmid W, Schutz G, Schule R, Renkawitz R. Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid response elements. EMBO J 1987; 6: 625-630 54 de The H, Vicanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A. Identifcation of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 1990; 343: 177-180 55 Huber R, Carrell RW. Implications of the three-dimensional structure of al-antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-8966
